EmeraMed
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NBMI Treatment in Patients With Mercury Toxicity (NCT04183595) | EmeraMed | 2023-11-22 |
| Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation (NCT04092205) | EmeraMed | 2019-11-21 |
| Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA) (NCT04184063) | EmeraMed | 2019-09-16 |
Track EmeraMed automatically
Every clearance here is in the API, with alerts when new ones post.